ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.909,14
-0,25%
S&P 500
5.881,63
-0,43%
Dow Jones
42.544,22
-0,07%
Euro vs US Dollar
1,03498
0,00%
Bitcoin
94.427,87
1,12%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC

  6. Inhibitor Therapeutics Inc (QB) (INTI) Börsenkurse

Inhibitor Therapeutics Inc (QB)

Inhibitor Therapeutics Inc (QB) (INTI)

USOTC
0,0601
0,0001
(0,17%)
Geschlossen 01 Januar 10:00PM
Verzögert um 15 Minuten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
0,0601
Gebot
0,0501
Fragen
0,0799
Volumen
32.201
0,06 Tagesbereich 0,06925
0,03355 52-Wochen-Bereich 0,1376
Marktkapitalisierung
10,357M
Handelsende
0,06
Handelsbeginn
0,06
Letzte Trade
1
@
0.054
Letzter Handelszeitpunkt
Finanzvolumen
US$ 1.979
VWAP
0,061458
Durchschnittliches Volumen (3 Mio.)
47.927
Ausgegebene Aktien
172.323.545
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-3,41
Gewinn pro Aktie (EPS)
-0,02
Erlöse
-
Nettogewinn
-3,03M

Über Inhibitor Therapeutics Inc (QB)

Inhibitor Therapeutics is a biopharmaceutical company that is seeking to discover, develop and commercialize innovative therapeutics for patients with certain cancers Inhibitor Therapeutics is a biopharmaceutical company that is seeking to discover, develop and commercialize innovative therapeutics for patients with certain cancers

Sektor
Coml Physical, Biologcl Resh
Branche
Coml Physical, Biologcl Resh
Website
www.inhibitortx.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Inhibitor Therapeutics Inc (QB) is listed in the Coml Physical, Biologcl Resh sector of the OTCMarkets with ticker INTI. The last closing price for Inhibitor Therapeutics (QB) was US$0,06. Over the last year, Inhibitor Therapeutics (QB) shares have traded in a share price range of US$ 0,03355 to US$ 0,1376.

Inhibitor Therapeutics (QB) currently has 172.323.545 shares in issue. The market capitalisation of Inhibitor Therapeutics (QB) is US$10,34 million. Inhibitor Therapeutics (QB) has a price to earnings ratio (PE ratio) of -3.41.

INTI Neueste Nachrichten

Weitere Nachrichten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

12 November 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

06 August 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

16 Mai 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

16 Mai 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

16 Mai 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

16 Mai 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

16 Mai 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

13 Mai 2024
Edgar (US Regulatory)

Form 8-K - Current report

14 Dezember 2023
Edgar (US Regulatory)

Form 8-K - Current report

18 Oktober 2023
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.00010.1666666666670.060.07840.0687290.06215068CS
4-0.0122-16.87413554630.07230.0840.042529600.07189322CS
12-0.0297-33.07349665920.08980.094950.042479270.07611646CS
26-0.0199-24.8750.080.09880.042409610.07645004CS
52-0.0599-49.91666666670.120.13760.03355285100.07780471CS
156-0.0848-58.52311939270.14490.29990.0131256880.0656038CS
2600.004357.802690582960.055750.3490.0131270730.08005222CS

INTI - Frequently Asked Questions (FAQ)

What is the current Inhibitor Therapeutics (QB) share price?
The current share price of Inhibitor Therapeutics (QB) is US$ 0,0601
How many Inhibitor Therapeutics (QB) shares are in issue?
Inhibitor Therapeutics (QB) has 172.323.545 shares in issue
What is the market cap of Inhibitor Therapeutics (QB)?
The market capitalisation of Inhibitor Therapeutics (QB) is USD 10,34M
What is the 1 year trading range for Inhibitor Therapeutics (QB) share price?
Inhibitor Therapeutics (QB) has traded in the range of US$ 0,03355 to US$ 0,1376 during the past year
What is the PE ratio of Inhibitor Therapeutics (QB)?
The price to earnings ratio of Inhibitor Therapeutics (QB) is -3,41
What is the reporting currency for Inhibitor Therapeutics (QB)?
Inhibitor Therapeutics (QB) reports financial results in USD
What is the latest annual profit for Inhibitor Therapeutics (QB)?
The latest annual profit of Inhibitor Therapeutics (QB) is USD -3,03M
What is the registered address of Inhibitor Therapeutics (QB)?
The registered address for Inhibitor Therapeutics (QB) is 108 W. 13TH STREET SUITE 100, WILMINGTON, DELAWARE, 19801
What is the Inhibitor Therapeutics (QB) website address?
The website address for Inhibitor Therapeutics (QB) is www.inhibitortx.com
Which industry sector does Inhibitor Therapeutics (QB) operate in?
Inhibitor Therapeutics (QB) operates in the COML PHYSICAL, BIOLOGCL RESH sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
EWGFFEat Well Investment Group Inc (CE)
US$ 0,02
(1.999.900,00%)
1,1k
EHVVFEhave Inc (CE)
US$ 0,0075
(749.900,00%)
7,03M
RKFLRocketFuel Blockchain Inc (CE)
US$ 0,0011
(109.900,00%)
4,2k
EGRNFChina Evergrande Group (CE)
US$ 0,0102
(101.900,00%)
9,3k
TWOHTwo Hands Corporation (PK)
US$ 0,0008
(79.900,00%)
1,65B
HOILFHunter Technology Corporation (CE)
US$ 0,000001
(-100,00%)
250
GLGLFGLG Life Tech Corporation (CE)
US$ 0,000001
(-99,99%)
6k
NTACNew Technology Acquisition Holdings (CE)
US$ 0,000001
(-99,75%)
6k
RBSHRebus Holdings Inc (CE)
US$ 0,000001
(-99,50%)
203k
ZPASZoompass Holdings Inc (CE)
US$ 0,000001
(-99,50%)
3k
TWOHTwo Hands Corporation (PK)
US$ 0,0008
(79.900,00%)
1,65B
HCMCHealthier Choices Management Corporation (PK)
US$ 0,000001
(0,00%)
224,2M
HMBLHUMBL Inc (PK)
US$ 0,00085
(-5,56%)
198,01M
THBDThird Bench Inc (PK)
US$ 0,0001
(-50,00%)
129,17M
PHILPHI Group Inc (PK)
US$ 0,0003
(-40,00%)
125,84M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

USOTC
INTI
Inhibitor Therapeutics (QB)
BOV
RENT3
LOCALIZA ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten